TONYA RUSHING: Open Payments
NPI 1922653849 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 7 payments from 5 companies in 2025. Trend: 2023 $218 · 2024 $441 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $13 |
Products named: BREZTRI, TRELEGY ELLIPTA, INGREZZA, QULIPTA, CAPLYTA.
Industry payments across MS — which companies pay providers there.
